Trials / Completed
CompletedNCT00214734
ADVATE Post Authorization Safety Surveillance
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 108 (actual)
- Sponsor
- Baxalta now part of Shire · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of this post-authorization safety surveillance is to measure the incidence of adverse events that are at least possibly related to ADVATE use, in subjects receiving ADVATE in routine clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rAHF-PFM |
Timeline
- Start date
- 2004-10-14
- Completion
- 2007-03-02
- First posted
- 2005-09-22
- Last updated
- 2021-03-17
Locations
37 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00214734. Inclusion in this directory is not an endorsement.